Archives
-
3-Deazaadenosine: From Methylation to Translation
2026-09-18
A translational perspective on 3-Deazaadenosine as an S-adenosylhomocysteine hydrolase inhibitor, linking methylation biology, ulcerative colitis research, and preclinical antiviral strategy. The article explains how to use the compound as a mechanistic probe while separating pharmacological methylation pressure from gene-specific perturbation.
-
Nadolol (SQ-11725) Research Workflows
2026-09-18
Nadolol (SQ-11725) supports controlled beta-adrenergic blockade in cardiovascular assays while also enabling transporter-aware pharmacokinetic experiments. This practical guide combines receptor signaling workflows with lessons from a 2025 tissue-distribution study to improve dosing, sampling, and troubleshooting.
-
Cell and Reporter Choice in mRNA-LNP Assays
2026-09-17
Zhen et al. show that cell-line and reporter selection can substantially change apparent mRNA-LNP transfection efficiency, dose response, and assay reproducibility. HEK 293T cells and eGFP produced the most consistent in-vitro measurements, whereas luciferase performance varied by cell type and among technical replicates.
-
ARCA EGFP mRNA (5-moUTP) Workflow Guide
2026-09-17
ARCA EGFP mRNA (5-moUTP) provides a direct, fluorescence-based readout for delivery and translation in mammalian cells without requiring plasmid transcription. Its ARCA cap, 5-moUTP chemistry, and optimized poly(A) tail support consistent reporter performance while disciplined cold-chain handling improves assay reproducibility.
-
Vacuolin-1: Lysosomal Exocytosis Inhibitor
2026-09-16
Vacuolin-1 is a cell-permeable lysosomal exocytosis inhibitor that blocks Ca2+-dependent lysosome–plasma membrane fusion. Its selective activity supports β-hexosaminidase release assays, membrane-repair studies, and mechanistic analysis of lysosome-mediated membrane trafficking.
-
FerroOrange for Live-Cell Fe²⁺ Detection
2026-09-15
FerroOrange is a live-cell Fe²⁺ fluorescent probe for connecting intracellular iron detection with microscopy, flow cytometry, and plate-based assays. This workflow guide translates the Cdk5–AMPK ferroptosis findings in ischemic injury into practical assay design, controls, and troubleshooting decisions.
-
REV1–DHX36 Coordinates G-Quadruplex Tolerance
2026-09-15
The reference study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its findings establish REV1 as more than a translesion polymerase scaffold: it also regulates helicase activity and cellular tolerance of stabilized G-quadruplex DNA.
-
40 Hz GENUS Limits Epileptogenesis via the dLGN Shell
2026-09-14
Wang and colleagues show that chronic 40 Hz light flicker reduces epileptogenesis-related pathology and seizure susceptibility in a pilocarpine status epilepticus mouse model. The study further identifies a retina–dorsal lateral geniculate nucleus shell–visual cortex pathway that links sensory gamma entrainment to parvalbumin-interneuron activity.
-
Golgi-Tracker Green in Translational Oncology
2026-09-14
A mechanistic and strategic guide to using Golgi-Tracker Green for live-cell Golgi imaging, lipid trafficking studies, and translational investigation of Golgi stress in hormone receptor-positive breast cancer.
-
Troxerutin Targets TRPM7 in Diabetic Cognitive Dysfunction
2026-09-13
This study identifies a TRPM7–calcineurin–Drp1Ser637 axis that links calcium dysregulation to mitochondrial fission, neuronal apoptosis, and diabetic cognitive dysfunction. Using db/db mice and high-glucose HT22 neurons, the authors show that troxerutin improves cognitive and mitochondrial outcomes by suppressing this pathway, while also defining important limits for translation beyond the experimental models.
-
DAPI in Microbiome-Driven Cancer Research
2026-09-12
The Prevotella copri–IPyA–UHRF1–AMPK axis illustrates why translational researchers need both mechanistic assays and disciplined phenotypic quality control. This article explains how DAPI and 4',6-Diamidino-2-Phenylindole can support nuclear visualization, apoptosis-oriented analysis, viability assessment, and flow cytometry without being mistaken for a pathway-specific biomarker.
-
o-Agatoxin IVA and Excitotoxicity in Cortical Neurons
2026-09-11
The 1996 study by Lustig, Ahern, and Greenberg tested whether o-Agatoxin IVA could protect cultured cortical neurons from excitotoxic injury triggered by veratridine, ouabain, or NMDA. Its central finding was that blocking P/Q- and Q-type calcium channels did not reduce LDH-defined neuronal toxicity, emphasizing that inhibition of glutamate release is not necessarily sufficient for neuroprotection.
-
Reserpine (N1867): Practical Lab Workflow
2026-09-11
Reserpine (SKU N1867) provides a defined research reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. This guide covers identity checks, DMSO preparation, storage, QC, and troubleshooting; it does not support diagnostic, therapeutic, clinical, or veterinary use.
-
Saikosaponins Target Smoothened in Medulloblastoma
2026-09-10
The 2022 Journal of Natural Medicines study shows that saikosaponins B1 and D suppress Hedgehog signaling at the Smoothened level and inhibit medulloblastoma allograft growth. Its combination of pathway reporter assays, downstream bypass experiments, and in vivo testing provides a useful framework for distinguishing Smoothened-dependent effects from nonspecific pathway suppression.
-
METTL9 and Cross-Kingdom Antifungal Defense
2026-09-10
The reference study identifies secreted intestinal METTL9 as a catalytic mucosal defense that methylates the Candida albicans zincophore PRA1, disrupting fungal zinc acquisition and limiting colonization. Its findings introduce nutritional sabotage as a distinct antifungal mechanism and provide a framework for comparing host-derived defenses with conventional drug-resistance research.